Berenguer, J, Ryan, P, Lutz, T, Martin-Carbonero, L, Pérez-Latorre, L, Vivancos, MJ, Navarro, J, Navarro-Soler, R, Ferrero, OL, Palacios, R, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero-Alonso, M, Killer, A, Malin, J, De los Santos, I, Esser, S, Morano, LE, López, I, Valencia, J, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, Cielniak, I, Van Bremen, K, Pérez-Somarriba, J, Sanz, J, Rozplochowski, B, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Fariñas, C, Raczynska, A, Voit, F, Qurishi, N, Noe, S, Reus, S, Khaykin, P, Schneeweiss, S, Wandeler, G, Boyd, A, De Miguel, M, Bellón, JM, Parczewski, M, Rockstroh, J. Hepatocellular carcinoma screening in HIV/HBV coinfected individuals: insights from Spain, Germany, and Poland. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Ryan, P, Berenguer, J, Lutz, T, Martín-Carbonero, L, Pérez-Latorre, L, Vivancos, MJ, Navarro, J, Navarro-Soler, R, Ferrero, OL, Palacios, R, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero-Alonso, M, Killer, A, Malin, JJ, De los Santos, I, Esser, S, Morano, LE, López, I, Cuevas, G, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, Cielniak, I, Van Bremen, K, Pérez-Somarriba, J, Sanz, J, Rozplochowski, B, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Armiñanzas, C, Raczynska, A, Voit, F, Qurishi, N, Christensen, S, Szymczak, A, Hlebowicz, M, Schwarze-zander, C, Jessen, A, Boyd, A, De Miguel, M, Bellon, JM, Parczewski, M, Rockstroh, J. Prevalence and factors associated with liver cirrhosis in people with HIV and chronic hepatitis B: a cross-sectional study in Spain, Germany, and Poland. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Bernabé, R, De Castro, J, Collado, R, Escudero, V, Gutiérrez, F, Arranz, S, Gordo, R, Arroyo, I, Majem, M. Economic Burden of Disease Management and Recurrences After Complete Resection of Early-Stage ALK plus Non-Small Cell Lung Cancer (NSCLC) in Spain. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).

Johnson, ML, Arriola, E, Kato, T, Girard, N, Gadgeel, S, Tarruella, MM, Newsom-Davis, T, Polaczek, M, Chen, X, Stefaniak, K, Lowery, C, Angra, N, Doherty, G, Ahn, MJ. Phase 3 eVOLVE-Lung02 Trial of Volrustomig plus Chemotherapy (CT) vs Pembrolizumab plus CT in Metastatic NSCLC With PD-L1 TC <50%. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).